- Home
- EDSA vs GIGM Comparison
EDSA vs GIGM Comparison
Compare EDSA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- GIGM
- Stock Information
- Founded
- EDSA 2015
- GIGM 1998
- Country
- EDSA Canada
- GIGM Taiwan
- Employees
- EDSA N/A
- GIGM N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- EDSA Health Care
- GIGM Technology
- Exchange
- EDSA Nasdaq
- GIGM Nasdaq
- Market Cap
- EDSA 13.7M
- GIGM 14.5M
- IPO Year
- EDSA N/A
- GIGM 2000
- Fundamental
- Price
- EDSA $4.28
- GIGM $1.34
- Analyst Decision
- EDSA Strong Buy
- GIGM
- Analyst Count
- EDSA 2
- GIGM 0
- Target Price
- EDSA $39.00
- GIGM N/A
- AVG Volume (30 Days)
- EDSA 8.9K
- GIGM 12.1K
- Earning Date
- EDSA 08-09-2024
- GIGM 10-29-2024
- Dividend Yield
- EDSA N/A
- GIGM N/A
- EPS Growth
- EDSA N/A
- GIGM N/A
- EPS
- EDSA N/A
- GIGM N/A
- Revenue
- EDSA N/A
- GIGM $3,387,000.00
- Revenue This Year
- EDSA N/A
- GIGM N/A
- Revenue Next Year
- EDSA N/A
- GIGM N/A
- P/E Ratio
- EDSA N/A
- GIGM N/A
- Revenue Growth
- EDSA N/A
- GIGM N/A
- 52 Week Low
- EDSA $2.46
- GIGM $1.23
- 52 Week High
- EDSA $8.33
- GIGM $1.50
- Technical
- Relative Strength Index (RSI)
- EDSA 45.00
- GIGM 47.68
- Support Level
- EDSA $4.20
- GIGM $1.34
- Resistance Level
- EDSA $5.00
- GIGM $1.45
- Average True Range (ATR)
- EDSA 0.23
- GIGM 0.06
- MACD
- EDSA 0.01
- GIGM -0.00
- Stochastic Oscillator
- EDSA 14.29
- GIGM 23.53
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.